449 results on '"Snelling, Thomas"'
Search Results
2. Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adults (The Methodical evaluation and Optimisation of Targeted IncentiVes for Accessing Treatment of Early-stage hepatitis C: MOTIVATE-C): protocol for a dose-response randomised controlled study
3. Trimodal skin health programme for childhood impetigo control in remote Western Australia (SToP): a cluster randomised, stepped-wedge trial
4. Modeling COVID-19 disease processes by remote elicitation of causal Bayesian networks from medical experts
5. The AuTOMATIC trial: a study protocol for a multi-arm Bayesian adaptive randomised controlled trial of text messaging to improve childhood immunisation coverage
6. Coverage gaps in empiric antibiotic regimens used to treat serious bacterial infections in neonates and children in Southeast Asia and the Pacific
7. Systematic review of the effect of additional doses of oral rotavirus vaccine on immunogenicity and reduction in diarrhoeal disease among young children
8. Urinary tract infections in children: building a causal model-based decision support tool for diagnosis with domain knowledge and prospective data
9. Statistical analysis plan for the OPTIMUM study: optimising immunisation using mixed schedules, an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule
10. ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial
11. Applying causal inference and Bayesian statistics to understanding vaccine safety signals — a simulation study
12. The Impact of a Multifaceted Tertiary Pediatric Hospital’s Antimicrobial Stewardship Service
13. Outcomes and endpoints reported in studies of pulmonary exacerbations in people with cystic fibrosis: A systematic review
14. Whole-Cell Pertussis Vaccination and Decreased Risk of IgE-Mediated Food Allergy: A Nested Case-Control Study
15. Multi-Methods Evaluation of the Stop (See, Treat, Prevent) Trial: A Cluster Randomised, Stepped Wedge Trial to Support Healthy Skin
16. CP Global Clinical Trials Network, an International Trials Network for Cerebral Palsy: Global Prioritisation Process Using the Modified Delphi Method
17. The Platform Trial in COVID-19 Priming and Boosting (PICOBOO): The Immunogenicity, Reactogenicity, and Safety of Different COVID-19 Vaccinations Administered as a Second Booster (Fourth Dose) in Azd1222 Primed Individuals Aged 50-<70 Years Old
18. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
19. Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial
20. Effectiveness of Palivizumab against Respiratory Syncytial Virus: Cohort and Case Series Analysis
21. Answering the call: co-designing a global trials network for cerebral palsy
22. Identification of the determinants of incomplete vaccination in Australian children
23. Choosing primary endpoints for clinical trials of health care interventions
24. Clinician perceptions of research priorities for the management of noncritically ill patients admitted to hospital with SARS‐CoV‐2 infection.
25. A Randomized Trial of Nafamostat for Covid-19
26. Using causal directed acyclic graphs (DAGs) to select patient-important outcomes in transplantation trials—interventions to treat polyomavirus infection as an example
27. Coverage gaps in empiric antibiotic regimens used to treat serious bacterial infections in neonates and children in Southeast Asia and the Pacific
28. Transparent reporting of adaptive clinical trials using concurrently randomised cohorts
29. FeBRILe3: Safety Evaluation of Febrile Infant Guidelines Through Prospective Bayesian Monitoring
30. List of Contributors
31. Group A Streptococcus
32. Assessment of on-time vaccination coverage in population subgroups: A record linkage cohort study
33. The influence of incomplete case ascertainment on measures of vaccine efficacy
34. SMS-based interventions for improving child and adolescent vaccine coverage and timeliness: a systematic review
35. Histo-blood group antigen profile of Australian Aboriginal children and seropositivity following oral rotavirus vaccination
36. RSV prophylaxis use in high-risk infants in Western Australia, 2002-2013: a record linkage cohort study
37. The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis plan
38. Informing rubella vaccination strategies in East Java, Indonesia through transmission modelling
39. The SToP (See, Treat, Prevent) Skin Sores and Scabies Trial - a stepped wedge cluster randomised trial for skin disease control in remote Western Australia: Statistical analysis plan
40. Predicting the causative pathogen among children with pneumonia using a causal Bayesian network
41. Perinatal Risk Factors Associated With Gastroenteritis Hospitalizations in Aboriginal and Non-Aboriginal Children in Western Australia (2000–2012): A Record Linkage Cohort Study
42. Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children
43. Anticoagulation Strategies in Non–Critically Ill Patients with Covid-19
44. Review of the health impact of the oral rotavirus vaccine program in children under 5 years in Australia: 2006 – 2021
45. Impact of high coverage of monovalent human rotavirus vaccine on Emergency Department presentations for rotavirus gastroenteritis
46. Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trial
47. Study protocol for controlled human infection for penicillin G againstStreptococcus pyogenes: a double-blinded, placebo-controlled, randomised trial to determine the minimum concentration required to prevent experimental pharyngitis (the CHIPS trial)
48. Histo-blood Group Antigen status of Australian Aboriginal children and seropositivity following oral rotavirus vaccination
49. Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial
50. Anticoagulation and Antiplatelet Strategies in Non-Critically Ill Patients with Covid-19
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.